Is staff turnover holding you back? In some markets, healthcare personnel turnover is five times higher than unemployment. The average total turnover rate reported for healthcare employers in 2016 is 20.1%, up from 19.2% in 2015, according to Compdata Surveys’ national survey, Compensation Data Healthcare.
As retinal specialists, we are truly fortunate to live in a time where we have several treatment options for patients with diabetic macular edema (DME). A fluocinolone acetonide (FAc) intravitreal implant 0.19 mg (Iluvien, Alimera Sciences) is indicated for the treatment of DME in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in IOP.
Are you planning on going to a conference this year? As Howard Schultz, chairman and chief executive officer of Starbucks, summarized, knowledge and skill are your keys to earning more. Professional conference season is upon us. Which ones are you paying for you and your employees to attend? No matter how dedicated and organized your practice may be, it’s impossible to internally train each and every staff member to the high level of excellence your patients demand. Thoughtfully motivating and engaging employees takes a concerted and systemic approach to learning and skills training.
I see the beginning of 2017 as fresh. A year of fresh possibilities. It is new and brimming with fresh beginnings, filled with hopes and dreams. If you are not feeling it, perhaps you are ensnared in the gray world of A, B, and C. This ABC is a continuous loop. You are not sure how you got there or how to get out.
As we sit down together with our families and friends for Thanksgiving dinner this year, we thought reflecting on the great innovations in the field of ophthalmology since the turn of this new century seemed timely (a topic that is a natural by-product of the marriage between a retinal surgeon and a pediatric ophthalmologist!).
Regardless of the outcome of the presidential race, there is much about practice management and leadership to be learned from mainstream media’s coverage of the two front-runners’ race to the White House.
Well tolerated and effective, anti-VEGF therapy is the current gold standard to treat DME. However, one treatment simply does not fit all and VEGF may just be one piece of a much larger puzzle. The fact that some DME patients have a limited response to anti-VEGF therapy is representative of this concept; we are discovering that there are additional inflammatory mediators that may be crucial components to the DME picture.
When Martin Luther King said, “I have a dream,” he had a vision for people, not a program. Visionary leaders have the ability to communicate values and ideas in a way that connects. In your practice, they bring certainty into the uncertain world of reimbursement rates and rapid change. What is your capacity to bring vision and direction into times of uncertainty?